Logo image of MRVL

MARVELL TECHNOLOGY INC (MRVL) Stock Fundamental Analysis

NASDAQ:MRVL - Nasdaq - US5738741041 - Common Stock - Currency: USD

79.0086  -0.31 (-0.39%)

Fundamental Rating

5

Overall MRVL gets a fundamental rating of 5 out of 10. We evaluated MRVL against 110 industry peers in the Semiconductors & Semiconductor Equipment industry. MRVL scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. MRVL is not overvalued while it is showing excellent growth. This is an interesting combination.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

MRVL had positive earnings in the past year.
MRVL had a positive operating cash flow in the past year.
In the past 5 years MRVL always reported negative net income.
Each year in the past 5 years MRVL had a positive operating cash flow.
MRVL Yearly Net Income VS EBIT VS OCF VS FCFMRVL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B 1.5B

1.2 Ratios

The Return On Assets of MRVL (-2.45%) is worse than 63.64% of its industry peers.
MRVL has a Return On Equity of -3.69%. This is in the lower half of the industry: MRVL underperforms 62.73% of its industry peers.
MRVL has a Return On Invested Capital of 0.19%. This is comparable to the rest of the industry: MRVL outperforms 46.36% of its industry peers.
Industry RankSector Rank
ROA -2.45%
ROE -3.69%
ROIC 0.19%
ROA(3y)-3.17%
ROA(5y)-2.8%
ROE(3y)-4.64%
ROE(5y)-3.98%
ROIC(3y)N/A
ROIC(5y)N/A
MRVL Yearly ROA, ROE, ROICMRVL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10

1.3 Margins

With a Operating Margin value of 0.62%, MRVL perfoms like the industry average, outperforming 47.27% of the companies in the same industry.
The Gross Margin of MRVL (43.17%) is comparable to the rest of the industry.
MRVL's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 0.62%
PM (TTM) N/A
GM 43.17%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.69%
GM growth 5Y-3.85%
MRVL Yearly Profit, Operating, Gross MarginsMRVL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), MRVL is destroying value.
The number of shares outstanding for MRVL remains at a similar level compared to 1 year ago.
The number of shares outstanding for MRVL has been increased compared to 5 years ago.
Compared to 1 year ago, MRVL has a worse debt to assets ratio.
MRVL Yearly Shares OutstandingMRVL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M
MRVL Yearly Total Debt VS Total AssetsMRVL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

2.2 Solvency

MRVL has an Altman-Z score of 6.43. This indicates that MRVL is financially healthy and has little risk of bankruptcy at the moment.
MRVL has a Altman-Z score of 6.43. This is in the better half of the industry: MRVL outperforms 66.36% of its industry peers.
The Debt to FCF ratio of MRVL is 3.09, which is a good value as it means it would take MRVL, 3.09 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 3.09, MRVL is doing good in the industry, outperforming 60.91% of the companies in the same industry.
A Debt/Equity ratio of 0.22 indicates that MRVL is not too dependend on debt financing.
MRVL has a Debt to Equity ratio (0.22) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF 3.09
Altman-Z 6.43
ROIC/WACC0.02
WACC11.28%
MRVL Yearly LT Debt VS Equity VS FCFMRVL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B 15B

2.3 Liquidity

MRVL has a Current Ratio of 1.30. This is a normal value and indicates that MRVL is financially healthy and should not expect problems in meeting its short term obligations.
MRVL's Current ratio of 1.30 is on the low side compared to the rest of the industry. MRVL is outperformed by 86.36% of its industry peers.
MRVL has a Quick Ratio of 1.30. This is a bad value and indicates that MRVL is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.94, MRVL is doing worse than 88.18% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.3
Quick Ratio 0.94
MRVL Yearly Current Assets VS Current LiabilitesMRVL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

9

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 35.42% over the past year.
The Earnings Per Share has been growing by 18.92% on average over the past years. This is quite good.
MRVL shows a strong growth in Revenue. In the last year, the Revenue has grown by 21.60%.
The Revenue has been growing by 16.40% on average over the past years. This is quite good.
EPS 1Y (TTM)35.42%
EPS 3Y0.21%
EPS 5Y18.92%
EPS Q2Q%158.33%
Revenue 1Y (TTM)21.6%
Revenue growth 3Y8.93%
Revenue growth 5Y16.4%
Sales Q2Q%63.26%

3.2 Future

The Earnings Per Share is expected to grow by 34.12% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 22.60% on average over the next years. This is a very strong growth
EPS Next Y82.13%
EPS Next 2Y53.36%
EPS Next 3Y41.37%
EPS Next 5Y34.12%
Revenue Next Year43.61%
Revenue Next 2Y30.14%
Revenue Next 3Y25.73%
Revenue Next 5Y22.6%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
MRVL Yearly Revenue VS EstimatesMRVL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B 15B 20B
MRVL Yearly EPS VS EstimatesMRVL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6 8 10

5

4. Valuation

4.1 Price/Earnings Ratio

MRVL is valuated quite expensively with a Price/Earnings ratio of 40.52.
MRVL's Price/Earnings ratio is in line with the industry average.
The average S&P500 Price/Earnings ratio is at 27.11. MRVL is valued slightly more expensive when compared to this.
Based on the Price/Forward Earnings ratio of 21.40, the valuation of MRVL can be described as rather expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of MRVL indicates a somewhat cheap valuation: MRVL is cheaper than 69.09% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 35.78, MRVL is valued a bit cheaper.
Industry RankSector Rank
PE 40.52
Fwd PE 21.4
MRVL Price Earnings VS Forward Price EarningsMRVL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

MRVL's Enterprise Value to EBITDA is on the same level as the industry average.
MRVL's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. MRVL is cheaper than 63.64% of the companies in the same industry.
Industry RankSector Rank
P/FCF 49.72
EV/EBITDA 51.63
MRVL Per share dataMRVL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as MRVL's earnings are expected to grow with 41.37% in the coming years.
PEG (NY)0.49
PEG (5Y)2.14
EPS Next 2Y53.36%
EPS Next 3Y41.37%

3

5. Dividend

5.1 Amount

With a yearly dividend of 0.32%, MRVL is not a good candidate for dividend investing.
MRVL's Dividend Yield is a higher than the industry average which is at 2.47.
With a Dividend Yield of 0.32, MRVL pays less dividend than the S&P500 average, which is at 2.39.
Industry RankSector Rank
Dividend Yield 0.32%

5.2 History

The dividend of MRVL decreases each year by -0.14%.
MRVL has paid a dividend for at least 10 years, which is a reliable track record.
MRVL has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-0.14%
Div Incr Years0
Div Non Decr Years3
MRVL Yearly Dividends per shareMRVL Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.05 0.1 0.15 0.2

5.3 Sustainability

The earnings of MRVL are negative and hence is the payout ratio. MRVL will probably not be able to sustain this dividend level.
DP-42.22%
EPS Next 2Y53.36%
EPS Next 3Y41.37%
MRVL Yearly Income VS Free CF VS DividendMRVL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B 1.5B

MARVELL TECHNOLOGY INC

NASDAQ:MRVL (8/14/2025, 2:46:59 PM)

79.0086

-0.31 (-0.39%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)05-29 2025-05-29/amc
Earnings (Next)08-28 2025-08-28/amc
Inst Owners88.14%
Inst Owner Change-0.21%
Ins Owners0.18%
Ins Owner Change0.73%
Market Cap68.12B
Analysts82.13
Price Target92.69 (17.32%)
Short Float %3.47%
Short Ratio1.42
Dividend
Industry RankSector Rank
Dividend Yield 0.32%
Yearly Dividend0.24
Dividend Growth(5Y)-0.14%
DP-42.22%
Div Incr Years0
Div Non Decr Years3
Ex-Date07-11 2025-07-11 (0.06)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-0.56%
Min EPS beat(2)-0.87%
Max EPS beat(2)-0.25%
EPS beat(4)1
Avg EPS beat(4)0.35%
Min EPS beat(4)-1.06%
Max EPS beat(4)3.57%
EPS beat(8)3
Avg EPS beat(8)-0.7%
EPS beat(12)4
Avg EPS beat(12)-0.94%
EPS beat(16)7
Avg EPS beat(16)0.36%
Revenue beat(2)0
Avg Revenue beat(2)-0.91%
Min Revenue beat(2)-1.08%
Max Revenue beat(2)-0.74%
Revenue beat(4)1
Avg Revenue beat(4)-0.01%
Min Revenue beat(4)-1.08%
Max Revenue beat(4)2.09%
Revenue beat(8)1
Avg Revenue beat(8)-0.77%
Revenue beat(12)1
Avg Revenue beat(12)-1.02%
Revenue beat(16)2
Avg Revenue beat(16)-0.77%
PT rev (1m)-1.39%
PT rev (3m)-12.23%
EPS NQ rev (1m)-0.68%
EPS NQ rev (3m)-1.74%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.28%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.04%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.12%
Valuation
Industry RankSector Rank
PE 40.52
Fwd PE 21.4
P/S 10.48
P/FCF 49.72
P/OCF 40.32
P/B 5.12
P/tB N/A
EV/EBITDA 51.63
EPS(TTM)1.95
EY2.47%
EPS(NY)3.69
Fwd EY4.67%
FCF(TTM)1.59
FCFY2.01%
OCF(TTM)1.96
OCFY2.48%
SpS7.54
BVpS15.44
TBVpS-0.67
PEG (NY)0.49
PEG (5Y)2.14
Profitability
Industry RankSector Rank
ROA -2.45%
ROE -3.69%
ROCE 0.23%
ROIC 0.19%
ROICexc 0.2%
ROICexgc 1.37%
OM 0.62%
PM (TTM) N/A
GM 43.17%
FCFM 21.07%
ROA(3y)-3.17%
ROA(5y)-2.8%
ROE(3y)-4.64%
ROE(5y)-3.98%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.69%
GM growth 5Y-3.85%
F-Score7
Asset Turnover0.32
Health
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF 3.09
Debt/EBITDA 2.14
Cap/Depr 23.68%
Cap/Sales 4.91%
Interest Coverage 250
Cash Conversion 121.61%
Profit Quality N/A
Current Ratio 1.3
Quick Ratio 0.94
Altman-Z 6.43
F-Score7
WACC11.28%
ROIC/WACC0.02
Cap/Depr(3y)20.72%
Cap/Depr(5y)19.16%
Cap/Sales(3y)5.03%
Cap/Sales(5y)4.66%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)35.42%
EPS 3Y0.21%
EPS 5Y18.92%
EPS Q2Q%158.33%
EPS Next Y82.13%
EPS Next 2Y53.36%
EPS Next 3Y41.37%
EPS Next 5Y34.12%
Revenue 1Y (TTM)21.6%
Revenue growth 3Y8.93%
Revenue growth 5Y16.4%
Sales Q2Q%63.26%
Revenue Next Year43.61%
Revenue Next 2Y30.14%
Revenue Next 3Y25.73%
Revenue Next 5Y22.6%
EBIT growth 1Y108.67%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year91.85%
EBIT Next 3Y40.45%
EBIT Next 5Y34.57%
FCF growth 1Y34.19%
FCF growth 3Y30.02%
FCF growth 5Y38.4%
OCF growth 1Y29.73%
OCF growth 3Y27.07%
OCF growth 5Y36.08%